Sacral neuromodulation can significantly help MS patients with bladder control issues.
Researchers studied a treatment called sacral neuromodulation (SNM) for people with multiple sclerosis (MS) who have overactive bladders. They found that this treatment helped many patients reduce how often they needed to go to the bathroom during the day and night. For example, the average number of times patients went to the bathroom during the day dropped from 9 times to 7 times. Additionally, the feeling of having to rush to the bathroom decreased from 97% of patients to 58%. Most importantly, many patients continued to experience these improvements even five years later.
MS patients who struggle with bladder control issues should pay attention to these findings because improved bladder function can lead to a better quality of life. Just like fixing a leaky faucet makes your home more comfortable, addressing bladder problems can help you feel more confident and relaxed. Caregivers can also benefit from this information, as they can better support their loved ones if they know about effective treatments. Healthcare providers can use these findings to guide treatment options for their MS patients with similar issues. Overall, this study shows that there are helpful solutions available for managing bladder problems in MS.
One limitation of the study is that it only included a small number of patients, which means more research is needed to confirm these results for everyone with MS. Additionally, the effectiveness of the treatment may vary from person to person, so it might not work the same for everyone. It's important for MS patients to discuss all treatment options with their healthcare provider to find the best approach for their individual needs.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.